|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Inverness Medical Innovations Inc. (IMA.N), a maker of diagnostic tests. |
|---|---|
| Transferring Party | ACON Laboratories Inc., a maker of rapid diagnostic test kits. |
| Sector | Diagnostics |
| Date | March 20, 2009 |
| Analysis In 06, Inverness acquired Acon’s rapid diagnostics business for the U.S., Canada and Europe, and agreed if milestones were reached to acquire these businesses serving consumer, point-of-care and lab markets. Acon is retaining its other global in-vitro diagnostics businesses, including diabetes, clinical chemistry and immunoassay products. Deal value -- $200m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |